The Effect of Time on the Outcome of Periodontal Treatment.

December 14, 2024 updated by: Georgia Malamoudi, 251 Hellenic Air Force & VA General Hospital
Re-evaluation after non-surgical periodontal treatment remains an integral part of comprehensive periodontal therapy. This re-evaluation determines if a patient is in need either of surgical periodontal therapy or a personalized program of supportive periodontal treatment. However important, this time point is yet to be determined.This interventional study aims to clarify which is the best time to re-evaluate the therapeutic result after non-surgical periodontal treatment.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This randomized clinical trial aims to clarify which is the best time to re-evaluate the therapeutic result after non-surgical periodontal treatment. For this purpose the participants will be recruited among people who come to the Periodontal Department of 251 Hellenic Air Force Hospital for periodontal treatment. Each participant is going to submit informed consent in order to be included in the study. Patients with the diagnosis of Periodontitis will be submitted to non-surgical periodontal treatment with ultrasonic and manual scalers within two sessions, under local anaesthesia. The result of the treatment is going to be evaluated at 6, 12 and 24 weeks after treatment completion.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Systematically healthy adults
  • Informed consent form completion
  • Periodontitis Diagnosis
  • Patients not having received periodontal treatment since 12 months before

Exclusion Criteria:

  • Medical History that interferes with wound healing
  • Antibiotic and anti-inflammatory drugs intake
  • Medication that induces gingival enlargement
  • Pregnancy/ Lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Periodontitis patients
Periodontitis patients receiving non-surgical periodontal treatment.
Non-surgical periodontal treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Probing Pocket Depth 0
Time Frame: Baseline
The distance between the gingival margin and the base of the sulcus/pocket
Baseline
Probing Pocket Depth 1
Time Frame: 6 weeks after periodontal treatment
The distance between the gingival margin and the base of the sulcus/pocket
6 weeks after periodontal treatment
Probing Pocket Depth 2
Time Frame: 12 weeks after periodontal treatment
The distance between the gingival margin and the base of the sulcus/pocket
12 weeks after periodontal treatment
Probing Pocket Depth 3
Time Frame: 24 weeks after periodontal treatment
The distance between the gingival margin and the base of the sulcus/pocket
24 weeks after periodontal treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical attachment level
Time Frame: Baseline, 6, 12, 24 weeks after treatment
The distance between cementoenamel junction and the base of the sulcus/pocket
Baseline, 6, 12, 24 weeks after treatment
Plaque Index
Time Frame: Baseline, 6, 12, 24 weeks after treatment
Number of sites with presence of dental plaque/ total number of sites
Baseline, 6, 12, 24 weeks after treatment
Bleeding on Probing
Time Frame: Baseline, 6, 12, 24 weeks after treatment
Number of sites with presence of bleeding/total number of sites
Baseline, 6, 12, 24 weeks after treatment
Tooth Mobility
Time Frame: Baseline, 6, 12, 24 weeks after treatment
degree of tooth mobility
Baseline, 6, 12, 24 weeks after treatment
Furcation involvement
Time Frame: Baseline, 6, 12, 24 weeks after treatment
Presence or absence of furcation involvement and degree of furcation defect
Baseline, 6, 12, 24 weeks after treatment
matrix metalloproteinase
Time Frame: Baseline, 6, 12, 24 weeks after treatment
matrix metalloproteinase 8 levels in whole saliva
Baseline, 6, 12, 24 weeks after treatment
Oral Health Impact Profile (OHIP)-14 Questionnaire
Time Frame: Baseline, 6, 12, 24 weeks after treatment
Questionnaire
Baseline, 6, 12, 24 weeks after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: George Koukos, DDS, PhD, 251 Hellenic Air Force & VA Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 3, 2025

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 28, 2022

First Submitted That Met QC Criteria

December 7, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 14, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Periodontal treatment

Subscribe